CBD and Drug Interactions: What You Need to Know Before Starting
Affiliate Disclosure: This post may contain affiliate links. We may earn a commission if you purchase through our links at...
Read morePost-COVID syndrome (long COVID) affects millions with persistent fatigue, brain fog, breathing difficulties, and pain months after infection. The underlying mechanisms involve viral persistence, immune dysregulation, and endothelial dysfunction. CBD addresses multiple post-COVID pathways: anti-inflammatory effects reduce systemic inflammation, anxiolytic properties calm anxiety-driven symptoms, and neuroprotective actions support nerve function. While not a post-COVID cure, CBD offers symptom management when other approaches fall short.
Clinical research on CBD specifically for post-COVID is emerging. Studies on related conditions (chronic inflammation, neuropathy, anxiety) suggest potential benefit. A 2023 survey of post-COVID patients found 48% reported some symptom improvement with CBD. The most improved symptoms: brain fog (62% improvement), anxiety (70%), pain (58%), and sleep (65%). However, these are anecdotal—controlled trials are needed to establish efficacy definitively.
For post-COVID fatigue and brain fog, start with 15-20mg daily. For persistent pain, increase to 25-30mg. For anxiety, 10-15mg may suffice. Full-spectrum CBD appears to offer more benefit than isolate for post-COVID’s multi-system symptoms. Many long COVID patients report better results with consistent daily use (4-8 weeks) rather than sporadic dosing. Combination with other post-COVID support (breathing exercises, pacing, rehabilitation) improves outcomes.
Many post-COVID patients have POTS (postural orthostatic tachycardia), dysautonomia, or myalgic encephalomyelitis. CBD’s blood pressure-modulating properties may help dysautonomia. The compound’s muscle-relaxing effects support myalgic encephalomyelitis symptoms. For post-COVID cognitive dysfunction, CBD’s neuroprotective effects combined with sleep improvement support brain recovery. CBD doesn’t replace specialized post-COVID rehabilitation but complements it.

Interested in finding out more about what’s happening in the world of CBD and Medicinal Cannabis?
Head to CBD World News for the latest scientific research, clinical trials, and business news.
Abstract: Currently, there are no approved pharmacotherapies for addiction to cocaine and other psychostimulant drugs. Several studies have proposed that...
Read moreCredits: Albert Batalla†, Hella Janssen†, Shiral S. Gangadin and Matthijs G. Bossong († These authors contributed equally to this work.)...
Read moreAuthors: Kimberly A. Babson1 & James Sottile 2 & Danielle Morabito1 Publish Date: 27 March 2017 Published by: Springer Science+Business...
Read more